AI and cognitive impairment | Physician performance measured in data

AI algorithm developed at Purdue and IU

DANVILLE, PA—Along with Japanese pharmaceutical company Eisai, Geisinger Health System will study the potential of artificial intelligence by testing the effectiveness of an algorithm to identify individuals with cognitive impairment who may develop dementia. The algorithm was developed and tested by researchers at Purdue University and Indiana University.

Data-driven physician performance

EVANSTON, IL—A Northwestern University-led research team is developing a new way of measuring physician adherence to best practices. The data-driven method takes into consideration the characteristics of the patients seen by a physician (how sick a patient is, for example) in order to estimate an adjusted performance that more accurately captures the know-how of a set of physicians.

Novel therapy for brain tumors leads to clinical trial

MADISON, WI–A novel therapy studied at the Medical College of Wisconsin (MCW) Cancer Center has led to a clinical trial for the treatment of glioblastoma, a rare and aggressive form of brain cancer, yet the most common primary brain tumor in adults.

What makes Medical Alley the home for device innovation

MINNESOTA–Minnesota’s Medical Alley is the number-one health technology cluster in the world, according the the Minnesota Department of Employment and Economic Improvement, and Minnesota innovators hold the most medical device patents per capita in the United States. In this article, Paul Iaizzo, a professor in the University of Minnesota Medical School, talks about medical device innovation in Minnesota.